Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	TLR10 GABRE CCR2 ADORA2B FCER1G PDGFRB FPR1 OR9Q1 OR1E3 LMBR1 CD79B CCR5 OR10J4 OR6T1 OR6P1 FFAR4 PGR OR51F1	1.45e-08	1353	56	18	GO:0004888
GeneOntologyMolecularFunction	G protein-coupled receptor activity	CCR2 ADORA2B PDGFRB FPR1 OR9Q1 OR1E3 CCR5 OR10J4 OR6T1 OR6P1 FFAR4 PGR OR51F1	7.41e-07	884	56	13	GO:0004930
GeneOntologyMolecularFunction	L-glutamine, sodium:proton antiporter activity	SLC38A5 SLC38A3	7.73e-06	2	56	2	GO:0140830
GeneOntologyMolecularFunction	glycosylceramide flippase activity	ATP10B ATP10D	2.31e-05	3	56	2	GO:0140351
GeneOntologyMolecularFunction	chemokine (C-C motif) ligand 5 binding	CCR2 CCR5	2.31e-05	3	56	2	GO:0071791
GeneOntologyMolecularFunction	L-asparagine transmembrane transporter activity	SLC38A5 SLC38A3	4.62e-05	4	56	2	GO:0015182
GeneOntologyMolecularFunction	L-histidine transmembrane transporter activity	SLC38A5 SLC38A3	7.68e-05	5	56	2	GO:0005290
GeneOntologyMolecularFunction	amino acid:monoatomic cation antiporter activity	SLC38A5 SLC38A3	7.68e-05	5	56	2	GO:0140848
GeneOntologyMolecularFunction	L-glutamine transmembrane transporter activity	SLC38A5 SLC38A3	2.75e-04	9	56	2	GO:0015186
GeneOntologyMolecularFunction	aromatic amino acid transmembrane transporter activity	SLC38A5 SLC38A3	5.91e-04	13	56	2	GO:0015173
GeneOntologyMolecularFunction	azole transmembrane transporter activity	SLC38A5 SLC38A3	6.88e-04	14	56	2	GO:1901474
GeneOntologyMolecularFunction	alanine transmembrane transporter activity	SLC38A5 SLC38A3	9.04e-04	16	56	2	GO:0022858
GeneOntologyMolecularFunction	sodium:proton antiporter activity	SLC38A5 SLC38A3	9.04e-04	16	56	2	GO:0015385
GeneOntologyMolecularFunction	flippase activity	ATP10B ATP10D	1.02e-03	17	56	2	GO:0140327
GeneOntologyMolecularFunction	immune receptor activity	CCR2 FCER1G FPR1 CCR5	1.18e-03	165	56	4	GO:0140375
GeneOntologyMolecularFunction	olfactory receptor activity	OR9Q1 OR1E3 OR10J4 OR6T1 OR6P1 OR51F1	1.27e-03	431	56	6	GO:0004984
GeneOntologyMolecularFunction	sphingolipid transporter activity	ATP10B ATP10D	1.42e-03	20	56	2	GO:0046624
GeneOntologyMolecularFunction	basic amino acid transmembrane transporter activity	SLC38A5 SLC38A3	1.42e-03	20	56	2	GO:0015174
GeneOntologyMolecularFunction	C-C chemokine receptor activity	CCR2 CCR5	1.88e-03	23	56	2	GO:0016493
GeneOntologyMolecularFunction	C-C chemokine binding	CCR2 CCR5	2.05e-03	24	56	2	GO:0019957
GeneOntologyMolecularFunction	G protein-coupled chemoattractant receptor activity	CCR2 CCR5	2.40e-03	26	56	2	GO:0001637
GeneOntologyMolecularFunction	chemokine receptor activity	CCR2 CCR5	2.40e-03	26	56	2	GO:0004950
GeneOntologyMolecularFunction	metal cation:proton antiporter activity	SLC38A5 SLC38A3	2.59e-03	27	56	2	GO:0051139
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ATP10B ATP10D	2.79e-03	28	56	2	GO:0140326
GeneOntologyMolecularFunction	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	HSD17B13 NSDHL	3.86e-03	33	56	2	GO:0033764
GeneOntologyMolecularFunction	chemokine binding	CCR2 CCR5	3.86e-03	33	56	2	GO:0019956
GeneOntologyMolecularFunction	steroid dehydrogenase activity	HSD17B13 NSDHL	5.36e-03	39	56	2	GO:0016229
GeneOntologyMolecularFunction	neutral L-amino acid transmembrane transporter activity	SLC38A5 SLC38A3	5.91e-03	41	56	2	GO:0015175
GeneOntologyMolecularFunction	amide transmembrane transporter activity	SLC38A5 SLC38A3	6.19e-03	42	56	2	GO:0042887
GeneOntologyMolecularFunction	metal cation:monoatomic cation antiporter activity	SLC38A5 SLC38A3	6.48e-03	43	56	2	GO:0140828
GeneOntologyBiologicalProcess	asparagine transmembrane transport	SLC38A5 SLC38A3	6.98e-06	2	55	2	GO:1903713
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	CCR2 ADORA2B PDGFRB FPR1 OR9Q1 OR1E3 CCR5 OR10J4 APOC3 OR6T1 OR6P1 FFAR4 PGR OR51F1	1.23e-05	1395	55	14	GO:0007186
GeneOntologyBiologicalProcess	asparagine transport	SLC38A5 SLC38A3	4.17e-05	4	55	2	GO:0006867
GeneOntologyBiologicalProcess	dendritic cell chemotaxis	SLAMF8 CCR2 CCR5	6.24e-05	29	55	3	GO:0002407
GeneOntologyBiologicalProcess	L-glutamine import across plasma membrane	SLC38A5 SLC38A3	6.95e-05	5	55	2	GO:1903803
GeneOntologyBiologicalProcess	L-histidine transmembrane transport	SLC38A5 SLC38A3	1.04e-04	6	55	2	GO:0089709
GeneOntologyBiologicalProcess	dendritic cell migration	SLAMF8 CCR2 CCR5	1.20e-04	36	55	3	GO:0036336
GeneOntologyCellularComponent	cell surface	SLAMF8 CCR2 ADORA2B FCER1G CD244 PDGFRB IFITM3 MRC2 BTN2A3P ERMAP LRP4 CD79B CCR5 BTN2A1 TREML2	1.44e-07	1111	56	15	GO:0009986
GeneOntologyCellularComponent	external side of plasma membrane	CCR2 FCER1G CD244 BTN2A3P ERMAP CD79B CCR5 BTN2A1	6.82e-05	519	56	8	GO:0009897
GeneOntologyCellularComponent	side of membrane	CCR2 FCER1G CD244 BTN2A3P ERMAP CD79B CCR5 HID1 BTN2A1	4.89e-04	875	56	9	GO:0098552
GeneOntologyCellularComponent	phospholipid-translocating ATPase complex	ATP10B ATP10D	6.28e-04	14	56	2	GO:1990531
MousePheno	abnormal response to cardiac infarction	CCR2 ADORA2B FCER1G RNLS CCR5	6.75e-06	94	40	5	MP:0000343
MousePheno	increased alcohol consumption	CCR2 CCR5 UNC79	9.64e-06	15	40	3	MP:0003545
MousePheno	increased immunoglobulin level	CCR2 FCER1G BTN2A3P CD79B CCR5 DSG4 BTN2A1	2.21e-05	305	40	7	MP:0002461
MousePheno	decreased urine ammonia level	RHCG SLC38A3	2.39e-05	3	40	2	MP:0011736
MousePheno	abnormal conditioned taste aversion behavior	CCR2 C1QL3 CCR5	2.79e-05	21	40	3	MP:0002805
MousePheno	impaired behavioral response to anesthetic	GABRE UNC79	7.94e-05	5	40	2	MP:0009778
MousePheno	abnormal urine ammonia level	RHCG SLC38A3	1.19e-04	6	40	2	MP:0011734
MousePheno	increased response to antigen	BTN2A3P BTN2A1	1.19e-04	6	40	2	MP:0020002
MousePheno	abnormal alcohol consumption	CCR2 CCR5 UNC79	1.33e-04	35	40	3	MP:0001425
MousePheno	clinodactyly	PDGFRB NSDHL	1.66e-04	7	40	2	MP:0006253
MousePheno	bronchiolitis	CCR2 CCR5	1.66e-04	7	40	2	MP:0031054
MousePheno	abnormal response to antigen	SLAMF8 CCR2 ZDHHC11B FCER1G IFITM3 FPR1 BTN2A3P CCR5 BTN2A1	1.67e-04	726	40	9	MP:0020000
MousePheno	decreased susceptibility to injury	CCR2 ADORA2B FCER1G CCR5 PANX2	2.17e-04	194	40	5	MP:0005166
MousePheno	brachypodia	LRP4 NSDHL	2.21e-04	8	40	2	MP:0002772
MousePheno	increased trabecular bone thickness	CCR2 LRP4 PGR	2.47e-04	43	40	3	MP:0009347
MousePheno	abnormal IgG1 level	FCER1G BTN2A3P CD79B CCR5 BTN2A1	2.50e-04	200	40	5	MP:0020175
MousePheno	abnormal response to injury	CCR2 ADORA2B FCER1G RNLS PDGFRB CCR5 PANX2 PGR	2.71e-04	607	40	8	MP:0005164
MousePheno	deformed nails	LRP4 DSG4	2.84e-04	9	40	2	MP:0000580
MousePheno	increased IgG2c level	BTN2A3P BTN2A1	4.32e-04	11	40	2	MP:0008896
MousePheno	abnormal cellular extravasation	CCR2 ADORA2B CCR5	4.35e-04	52	40	3	MP:0009858
MousePheno	abnormal leukocyte adhesion	CCR2 ADORA2B CCR5	5.14e-04	55	40	3	MP:0003628
MousePheno	decreased autopod size	LRP4 NSDHL	5.17e-04	12	40	2	MP:0014291
MousePheno	abnormal behavioral response to anesthetic	GABRE UNC79	5.17e-04	12	40	2	MP:0009777
MousePheno	abnormal immunoglobulin level	CCR2 FCER1G BTN2A3P CD79B CCR5 DSG4 BTN2A1	5.60e-04	513	40	7	MP:0002490
MousePheno	abnormal NK T cell physiology	FCER1G CCR5	7.11e-04	14	40	2	MP:0008042
MousePheno	abnormal IgG level	CCR2 FCER1G BTN2A3P CD79B CCR5 BTN2A1	8.01e-04	392	40	6	MP:0020174
MousePheno	abnormal autopod size	LRP4 NSDHL	8.19e-04	15	40	2	MP:0014290
MousePheno	increased bone strength	CCR2 LRP4	9.34e-04	16	40	2	MP:0004149
MousePheno	short hair	DSG4 NSDHL	9.34e-04	16	40	2	MP:0000417
MousePheno	abnormal humoral immune response	CCR2 FCER1G BTN2A3P CD79B CCR5 DSG4 BTN2A1	9.80e-04	564	40	7	MP:0001800
MousePheno	abnormal guard hair morphology	DSG4 NSDHL	1.06e-03	17	40	2	MP:0000397
Domain	Chemokine_CCR5	CCR2 CCR5	7.60e-06	2	52	2	IPR002240
Domain	DUF1977	DNAJB12 DNAJB14	2.28e-05	3	52	2	PF09320
Domain	DUF1977_DnaJ-like	DNAJB12 DNAJB14	2.28e-05	3	52	2	IPR015399
Domain	IG_LIKE	SLAMF8 CD244 PDGFRB BTN2A3P ERMAP CD79B BTN2A1 TREML2	5.87e-05	491	52	8	PS50835
Domain	Ig-like_dom	SLAMF8 CD244 PDGFRB BTN2A3P ERMAP CD79B BTN2A1 TREML2	6.95e-05	503	52	8	IPR007110
Domain	C1Q	C1QL1 C1QL3 C1QL4	9.54e-05	32	52	3	SM00110
Domain	C1q	C1QL1 C1QL3 C1QL4	9.54e-05	32	52	3	PF00386
Domain	C1q_dom	C1QL1 C1QL3 C1QL4	1.15e-04	34	52	3	IPR001073
Domain	C1Q	C1QL1 C1QL3 C1QL4	1.15e-04	34	52	3	PS50871
Domain	V-set	BTN2A3P ERMAP CD79B BTN2A1 TREML2	1.57e-04	184	52	5	PF07686
Domain	ITAM	FCER1G CD79B	1.58e-04	7	52	2	SM00077
Domain	ITAM	FCER1G CD79B	1.58e-04	7	52	2	PF02189
Domain	Ig_V-set	BTN2A3P ERMAP CD79B BTN2A1 TREML2	2.26e-04	199	52	5	IPR013106
Domain	PRY	BTN2A3P ERMAP BTN2A1	3.22e-04	48	52	3	SM00589
Domain	PRY	BTN2A3P ERMAP BTN2A1	3.22e-04	48	52	3	IPR006574
Domain	Phos_immunorcpt_sig_ITAM	FCER1G CD79B	3.37e-04	10	52	2	IPR003110
Domain	ITAM_1	FCER1G CD79B	3.37e-04	10	52	2	PS51055
Domain	Hydrolase_3	ATP10B ATP10D	3.37e-04	10	52	2	PF08282
Domain	-	C1QL1 C1QL3 C1QL4	3.64e-04	50	52	3	2.60.120.40
Domain	GPCR_Rhodpsn_7TM	CCR2 ADORA2B FPR1 OR9Q1 CCR5 OR6T1 OR6P1 FFAR4	4.90e-04	670	52	8	IPR017452
Domain	7tm_1	CCR2 ADORA2B FPR1 OR9Q1 CCR5 OR6T1 OR6P1 FFAR4	5.25e-04	677	52	8	PF00001
Domain	Tumour_necrosis_fac-like_dom	C1QL1 C1QL3 C1QL4	5.64e-04	58	52	3	IPR008983
Domain	G_PROTEIN_RECEP_F1_1	CCR2 ADORA2B FPR1 OR9Q1 CCR5 OR6T1 OR6P1 FFAR4	5.67e-04	685	52	8	PS00237
Domain	CD225	IFITM3 IFITM2	5.82e-04	13	52	2	PF04505
Domain	CD225/Dispanin_fam	IFITM3 IFITM2	5.82e-04	13	52	2	IPR007593
Domain	G_PROTEIN_RECEP_F1_2	CCR2 ADORA2B FPR1 OR9Q1 CCR5 OR6T1 OR6P1 FFAR4	6.01e-04	691	52	8	PS50262
Domain	GPCR_Rhodpsn	CCR2 ADORA2B FPR1 OR9Q1 CCR5 OR6T1 OR6P1 FFAR4	6.07e-04	692	52	8	IPR000276
Domain	P_typ_ATPase_c	ATP10B ATP10D	6.77e-04	14	52	2	IPR032630
Domain	P-type_ATPase_N	ATP10B ATP10D	6.77e-04	14	52	2	IPR032631
Domain	P-type_ATPase_IV	ATP10B ATP10D	6.77e-04	14	52	2	IPR006539
Domain	PhoLip_ATPase_C	ATP10B ATP10D	6.77e-04	14	52	2	PF16212
Domain	PhoLip_ATPase_N	ATP10B ATP10D	6.77e-04	14	52	2	PF16209
Domain	Ig-like_fold	SLAMF8 CD244 PDGFRB BTN2A3P ERMAP CD79B BTN2A1 TREML2	6.92e-04	706	52	8	IPR013783
Domain	Chemokine_rcpt	CCR2 CCR5	8.90e-04	16	52	2	IPR000355
Domain	Butyrophylin	BTN2A3P ERMAP BTN2A1	9.77e-04	70	52	3	IPR003879
Domain	Aa_trans	SLC38A5 SLC38A3	1.01e-03	17	52	2	PF01490
Domain	AA_transpt_TM	SLC38A5 SLC38A3	1.01e-03	17	52	2	IPR013057
Domain	IG	CD244 PDGFRB ERMAP CD79B BTN2A1 TREML2	1.07e-03	421	52	6	SM00409
Domain	Ig_sub	CD244 PDGFRB ERMAP CD79B BTN2A1 TREML2	1.07e-03	421	52	6	IPR003599
Domain	IGv	BTN2A3P ERMAP BTN2A1	1.19e-03	75	52	3	SM00406
Domain	Collagen	C1QL1 C1QL3 C1QL4	1.71e-03	85	52	3	PF01391
Domain	Collagen	C1QL1 C1QL3 C1QL4	1.71e-03	85	52	3	IPR008160
Domain	SPRY	BTN2A3P ERMAP BTN2A1	1.83e-03	87	52	3	SM00449
Domain	SPRY	BTN2A3P ERMAP BTN2A1	2.28e-03	94	52	3	PF00622
Domain	SPRY_dom	BTN2A3P ERMAP BTN2A1	2.28e-03	94	52	3	IPR003877
Domain	B30.2/SPRY	BTN2A3P ERMAP BTN2A1	2.35e-03	95	52	3	IPR001870
Domain	B302_SPRY	BTN2A3P ERMAP BTN2A1	2.35e-03	95	52	3	PS50188
Domain	DnaJ_domain_CS	DNAJB12 DNAJB14	2.55e-03	27	52	2	IPR018253
Domain	-	ATP10B ATP10D	3.57e-03	32	52	2	2.70.150.10
Domain	-	ATP10B ATP10D	3.57e-03	32	52	2	3.40.1110.10
Domain	ATPase_P-typ_cyto_domN	ATP10B ATP10D	4.27e-03	35	52	2	IPR023299
Domain	ATPase_P-typ_P_site	ATP10B ATP10D	4.51e-03	36	52	2	IPR018303
Domain	P_typ_ATPase	ATP10B ATP10D	4.51e-03	36	52	2	IPR001757
Domain	ATPASE_E1_E2	ATP10B ATP10D	4.51e-03	36	52	2	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP10B ATP10D	4.76e-03	37	52	2	IPR008250
Domain	E1-E2_ATPase	ATP10B ATP10D	4.76e-03	37	52	2	PF00122
Domain	PRY	ERMAP BTN2A1	6.10e-03	42	52	2	PF13765
Domain	DnaJ	DNAJB12 DNAJB14	7.90e-03	48	52	2	PF00226
Domain	DnaJ	DNAJB12 DNAJB14	8.22e-03	49	52	2	SM00271
Domain	DNAJ_1	DNAJB12 DNAJB14	8.22e-03	49	52	2	PS00636
Domain	DNAJ_2	DNAJB12 DNAJB14	8.22e-03	49	52	2	PS50076
Domain	-	DNAJB12 DNAJB14	8.22e-03	49	52	2	1.10.287.110
Domain	DnaJ_domain	DNAJB12 DNAJB14	8.88e-03	51	52	2	IPR001623
Domain	-	CD244 PDGFRB ERMAP CD79B BTN2A1 TREML2	9.95e-03	663	52	6	2.60.40.10
Pathway	WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT	CCR2 CCR5 IFITM2	6.55e-05	26	43	3	M46461
Pathway	REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS	BTN2A3P BTN2A1	3.23e-04	9	43	2	MM15487
Pathway	REACTOME_INTERLEUKIN_10_SIGNALING	CCR2 FPR1 CCR5	3.43e-04	45	43	3	M27605
Pubmed	The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins.	C1QL1 C1QL3 C1QL4	3.94e-08	5	56	3	21262840
Pubmed	Distinct expression of C1q-like family mRNAs in mouse brain and biochemical characterization of their encoded proteins.	C1QL1 C1QL3 C1QL4	7.88e-08	6	56	3	20525073
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	TLR10 SLAMF8 C1QL1 ADORA2B FCER1G CD244 FPR1 CD79B CCR5 BCL2L13	7.02e-07	824	56	10	20237496
Pubmed	Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.	CCR2 FCER1G CCR5	8.61e-07	12	56	3	21029863
Pubmed	pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.	IFITM3 IFITM2	2.55e-06	2	56	2	28356532
Pubmed	Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.	CCR2 CCR5	2.55e-06	2	56	2	14533004
Pubmed	Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologies.	CCR2 CCR5	2.55e-06	2	56	2	15230854
Pubmed	Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.	CCR2 CCR5	2.55e-06	2	56	2	11752157
Pubmed	CCR5 haplotypes and mother-to-child HIV transmission in Malawi.	CCR2 CCR5	2.55e-06	2	56	2	17786209
Pubmed	Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.	CCR2 CCR5	2.55e-06	2	56	2	24098976
Pubmed	CCR2 and CCR5 genotypes in HIV type 1-infected adolescents: limited contributions to variability in plasma HIV type 1 RNA concentration in the absence of antiretroviral therapy.	CCR2 CCR5	2.55e-06	2	56	2	11958683
Pubmed	CCR5 promoter human haplogroups associated with HIV-1 disease progression in Thai injection drug users.	CCR2 CCR5	2.55e-06	2	56	2	15362666
Pubmed	Polymorphism of CC chemokine receptors CCR2 and CCR5 in Crohn's disease.	CCR2 CCR5	2.55e-06	2	56	2	11377705
Pubmed	Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.	CCR2 CCR5	2.55e-06	2	56	2	22479344
Pubmed	Microinjection of Cre recombinase protein into zygotes enables specific deletion of two eukaryotic selection cassettes and enhances the expression of a DsRed2 reporter gene in Ccr2/Ccr5 double-deficient mice.	CCR2 CCR5	2.55e-06	2	56	2	19517561
Pubmed	Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection.	CCR2 CCR5	2.55e-06	2	56	2	19050266
Pubmed	Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.	CCR2 CCR5	2.55e-06	2	56	2	12556692
Pubmed	Blood pressure regulation by CCR genes.	CCR2 CCR5	2.55e-06	2	56	2	17060059
Pubmed	Polymorphism of CCR5 affecting HIV disease progression in the Japanese population.	CCR2 CCR5	2.55e-06	2	56	2	11485615
Pubmed	Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.	CCR2 CCR5	2.55e-06	2	56	2	19098363
Pubmed	DNAJB12 and DNJB14 are non-redundant Hsp40 redox chaperones involved in endoplasmic reticulum protein reflux.	DNAJB12 DNAJB14	2.55e-06	2	56	2	37925033
Pubmed	Chemokine receptor 2-V64I and chemokine receptor 5-Delta32 polymorphisms and clinical risk factors of delayed graft function and acute rejection in kidney transplantation.	CCR2 CCR5	2.55e-06	2	56	2	22218121
Pubmed	The effect of chemokine receptor gene polymorphisms (CCR2V64I, CCR5-59029G>A and CCR5Δ32) on renal allograft survival in Pakistani transplant patients.	CCR2 CCR5	2.55e-06	2	56	2	23041556
Pubmed	Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis.	CCR2 CCR5	2.55e-06	2	56	2	20153665
Pubmed	[Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].	CCR2 CCR5	2.55e-06	2	56	2	15769362
Pubmed	Lack of association of CCR gene polymorphisms and left ventricular hypertrophy in essential hypertension.	CCR2 CCR5	2.55e-06	2	56	2	16196460
Pubmed	Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Müller cells.	SLC38A5 SLC38A3	2.55e-06	2	56	2	16249471
Pubmed	Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.	CCR2 CCR5	2.55e-06	2	56	2	27895119
Pubmed	Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.	CCR2 CCR5	2.55e-06	2	56	2	16055130
Pubmed	Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.	CCR2 CCR5	2.55e-06	2	56	2	12884524
Pubmed	Effects of CCR2 and CCRS polymorphisms on HIV-1 infection in Thai females.	CCR2 CCR5	2.55e-06	2	56	2	18197127
Pubmed	Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.	CCR2 CCR5	2.55e-06	2	56	2	15213273
Pubmed	CCR5 and CCR2 gene polymorphisms in hypertensive patients.	CCR2 CCR5	2.55e-06	2	56	2	12680626
Pubmed	Genetic variations in CC chemokine receptors and hypertension.	CCR2 CCR5	2.55e-06	2	56	2	16461193
Pubmed	Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus.	CCR2 CCR5	2.55e-06	2	56	2	10854218
Pubmed	Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.	CCR2 CCR5	2.55e-06	2	56	2	12913933
Pubmed	Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.	CCR2 CCR5	2.55e-06	2	56	2	12853745
Pubmed	Polymorphisms in CCR5 chemokine receptor gene in Japan.	CCR2 CCR5	2.55e-06	2	56	2	17845302
Pubmed	CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse.	CCR2 CCR5	2.55e-06	2	56	2	19824873
Pubmed	Expression of DNAJB12 or DNAJB14 causes coordinate invasion of the nucleus by membranes associated with a novel nuclear pore structure.	DNAJB12 DNAJB14	2.55e-06	2	56	2	24732912
Pubmed	The genetic associations and epistatic effects of the CCR5 promoter and CCR2-V64I polymorphisms on susceptibility to HIV-1 infection in a Northern Han Chinese population.	CCR2 CCR5	2.55e-06	2	56	2	23057571
Pubmed	Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.	CCR2 CCR5	2.55e-06	2	56	2	10843684
Pubmed	Expression and function of system N glutamine transporters (SN1/SN2 or SNAT3/SNAT5) in retinal ganglion cells.	SLC38A5 SLC38A3	2.55e-06	2	56	2	18689705
Pubmed	Genetic contribution of chemokine receptor 2 (CCR2) polymorphisms towards increased serum total IgE levels in Indian asthmatics.	CCR2 CCR5	2.55e-06	2	56	2	19520154
Pubmed	Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.	CCR2 CCR5	2.55e-06	2	56	2	19037908
Pubmed	CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury.	FPR1 CCR5	2.55e-06	2	56	2	23860188
Pubmed	Frequency of polymorphisms of genes coding for HIV-1 co-receptors CCR5 and CCR2 in a Brazilian population.	CCR2 CCR5	2.55e-06	2	56	2	14533983
Pubmed	CCR2 and CCR5 genes polymorphisms in women with cervical lesions from Pernambuco, Northeast Region of Brazil: a case-control study.	CCR2 CCR5	2.55e-06	2	56	2	26982176
Pubmed	Chemokine CCL5 promotes robust optic nerve regeneration and mediates many of the effects of CNTF gene therapy.	CCR2 CCR5	2.55e-06	2	56	2	33627402
Pubmed	A multiethnic study of Delta32ccr5 and ccr2b-V64I allele distribution in four Los Angeles populations.	CCR2 CCR5	2.55e-06	2	56	2	11385319
Pubmed	Distribution of CCR5-Delta 32 and CCR2-64I alleles in an Argentine Amerindian population.	CCR2 CCR5	2.55e-06	2	56	2	11696224
Pubmed	Constitutive activation of CCR5 and CCR2 induced by conformational changes in the conserved TXP motif in transmembrane helix 2.	CCR2 CCR5	2.55e-06	2	56	2	12837756
Pubmed	CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.	CCR2 CCR5	2.55e-06	2	56	2	31320454
Pubmed	Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population.	CCR2 CCR5	2.55e-06	2	56	2	20182805
Pubmed	The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.	CCR2 CCR5	2.55e-06	2	56	2	15585333
Pubmed	Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria.	CCR2 CCR5	2.55e-06	2	56	2	23727176
Pubmed	Chemokine receptor genotype is associated with diabetic nephropathy in Japanese with type 2 diabetes.	CCR2 CCR5	2.55e-06	2	56	2	11756347
Pubmed	Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.	CCR2 CCR5	2.55e-06	2	56	2	15086346
Pubmed	CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis.	CCR2 CCR5	2.55e-06	2	56	2	34747459
Pubmed	Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.	CCR2 CCR5	2.55e-06	2	56	2	16316965
Pubmed	Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.	CCR2 CCR5	2.55e-06	2	56	2	17094383
Pubmed	Protection from pulmonary fibrosis in the absence of CCR2 signaling.	CCR2 CCR5	2.55e-06	2	56	2	11591761
Pubmed	Analysis of the involvement of CCR5-Delta32 and CCR2-V64I variants in the development of endometriosis.	CCR2 CCR5	2.55e-06	2	56	2	14981141
Pubmed	Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis.	CCR2 CCR5	2.55e-06	2	56	2	15067318
Pubmed	Effects of polymorphisms of chemokine receptors on neurodevelopment and the onset of encephalopathy in children with perinatal HIV-1 infection.	CCR2 CCR5	2.55e-06	2	56	2	17361671
Pubmed	Genetic diversity and linkage disequilibrium in the chemokine receptor CCR2-CCR5 region among individuals and populations.	CCR2 CCR5	2.55e-06	2	56	2	24011637
Pubmed	Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.	CCR2 CCR5	2.55e-06	2	56	2	11477473
Pubmed	Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.	CCR2 CCR5	2.55e-06	2	56	2	16140745
Pubmed	Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.	CCR2 CCR5	2.55e-06	2	56	2	21429204
Pubmed	Dominant effects of CCR2-CCR5 haplotypes in HIV-1 disease progression.	CCR2 CCR5	2.55e-06	2	56	2	15602133
Pubmed	Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.	CCR2 CCR5	2.55e-06	2	56	2	11596075
Pubmed	CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.	CCR2 CCR5	2.55e-06	2	56	2	12447757
Pubmed	Association study between CCR2-CCR5 genes polymorphisms and chronic Chagas heart disease in Wichi and in admixed populations from Argentina.	CCR2 CCR5	2.55e-06	2	56	2	30650073
Pubmed	Molecular analysis of a human interferon-inducible gene family.	IFITM3 IFITM2	2.55e-06	2	56	2	1906403
Pubmed	C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.	CCR2 CCR5	2.55e-06	2	56	2	12403355
Pubmed	CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.	CCR2 CCR5	2.55e-06	2	56	2	23632061
Pubmed	SNP/haplotype associations of CCR2 and CCR5 genes with severity of chagasic cardiomyopathy.	CCR2 CCR5	2.55e-06	2	56	2	25312802
Pubmed	Heterozygosity for CCR5-Delta32 but not CCR2b-64I protects against certain intracellular pathogens.	CCR2 CCR5	2.55e-06	2	56	2	12010355
Pubmed	Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of myocardial infarction among Tunisian male patients.	CCR2 CCR5	2.55e-06	2	56	2	22285384
Pubmed	Chemokine receptor genotype and response to interleukin-2 therapy in HIV-1-infected individuals.	CCR2 CCR5	2.55e-06	2	56	2	12584049
Pubmed	Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival.	CCR2 CCR5	2.55e-06	2	56	2	16598837
Pubmed	CCR2-64I allele is associated with the progression of AIDS in a Han Chinese population.	CCR2 CCR5	7.63e-06	3	56	2	19669591
Pubmed	Chemokine and chemokine receptor gene polymorphism in Tunisian hemodialysis patients with HCV infection.	CCR2 CCR5	7.63e-06	3	56	2	22026334
Pubmed	CCR4-dependent regulatory T cell function in inflammatory bowel disease.	CCR2 CCR5	7.63e-06	3	56	2	17548518
Pubmed	CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.	CCR2 CCR5	7.63e-06	3	56	2	10940868
Pubmed	Fraction of cases of acquired immunodeficiency syndrome prevented by the interactions of identified restriction gene variants.	CCR2 CCR5	7.63e-06	3	56	2	14742283
Pubmed	The association of genetic variants in chemokine genes with the risk of psoriasis vulgaris in Chinese population: A case-control study.	CCR2 CCR5	7.63e-06	3	56	2	29145242
Pubmed	Provincial distribution of three HIV-1 resistant polymorphisms (CCR5-Delta32, CCR2-64I, and SDF1-3' A) in China.	CCR2 CCR5	7.63e-06	3	56	2	18763111
Pubmed	IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.	IFITM3 IFITM2	7.63e-06	3	56	2	23720721
Pubmed	Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.	CCR2 CCR5	7.63e-06	3	56	2	14624371
Pubmed	Distribution of HIV-1 resistant polymorphisms among HIV infected patients in Georgia.	CCR2 CCR5	7.63e-06	3	56	2	19124913
Pubmed	Frequency of CCR5-Δ32, CCR2-64I and SDF1-3'A alleles in HIV-infected and uninfected patients in Istanbul, Turkey.	CCR2 CCR5	7.63e-06	3	56	2	34516427
Pubmed	Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease.	CCR2 CCR5	7.63e-06	3	56	2	16305685
Pubmed	Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease.	BTN2A3P BTN2A1	7.63e-06	3	56	2	37356345
Pubmed	Chemokine receptor polymorphisms and GB virus C status in HIV-positive patients.	CCR2 CCR5	7.63e-06	3	56	2	11964548
Pubmed	MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.	CCR2 CCR5	7.63e-06	3	56	2	15163738
Pubmed	CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.	CCR2 CCR5	7.63e-06	3	56	2	15192276
Pubmed	HIV infection and host genetic mutation among injecting drug-users of northeastern states of India.	CCR2 CCR5	7.63e-06	3	56	2	20411675
Pubmed	An intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes.	CCR2 CCR5	7.63e-06	3	56	2	22912822
Pubmed	IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.	IFITM3 IFITM2	7.63e-06	3	56	2	22479637
Interaction	POMT1 interactions	GABRE CD244 APOC3 NSDHL	1.11e-05	57	49	4	int:POMT1
Interaction	SMIM1 interactions	FCER1G HSD17B13 TMEM154 BCL2L13	1.27e-05	59	49	4	int:SMIM1
Interaction	TSPAN15 interactions	ADORA2B IFITM3 PIGW LMBR1 SLC38A5 SLC38A3	5.33e-05	276	49	6	int:TSPAN15
Interaction	CACNG6 interactions	PIGW LMBR1 SLC38A3	7.67e-05	34	49	3	int:CACNG6
Interaction	SGTA interactions	DNAJB12 TMEM154 C1QL4 CD79B DNAJB14 PGR	1.01e-04	310	49	6	int:SGTA
Interaction	HTR3A interactions	C1QL1 LMBR1 C1QL4 BTN2A1	1.37e-04	108	49	4	int:HTR3A
Interaction	TMUB2 interactions	CD79B OR6T1 BCL2L13	1.67e-04	44	49	3	int:TMUB2
Interaction	SQLE interactions	OR6T1 BCL2L13 TREML2	1.91e-04	46	49	3	int:SQLE
Interaction	TMEM19 interactions	FCER1G HSD17B13 TMEM154	1.91e-04	46	49	3	int:TMEM19
Interaction	ENTREP3 interactions	GABRE LMBR1 CD79B BTN2A1	2.06e-04	120	49	4	int:ENTREP3
Interaction	NCR3 interactions	C1QL1 FCER1G C1QL4 MMP15	2.06e-04	120	49	4	int:NCR3
Cytoband	Ensembl 112 genes in cytogenetic band chr1q23	SLAMF8 FCER1G CD244 OR10J4 OR6P1	8.61e-06	226	56	5	chr1q23
Cytoband	1q23.2	SLAMF8 OR10J4	8.47e-04	35	56	2	1q23.2
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	TLR10 SLAMF8 CCR2 CD244 PDGFRB MRC2 CD79B CCR5	7.08e-06	394	47	8	471
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN2A3P ERMAP BTN2A1	7.33e-06	15	47	3	458
GeneFamily	Endogenous ligands\|C1q and TNF related	C1QL1 C1QL3 C1QL4	1.31e-05	18	47	3	1372
GeneFamily	CD molecules\|C-C motif chemokine receptors	CCR2 CCR5	2.94e-04	10	47	2	1091
GeneFamily	ATPase phospholipid transporting	ATP10B ATP10D	6.80e-04	15	47	2	1210
GeneFamily	Adenosine receptors\|V-set domain containing	ERMAP CD79B BTN2A1 TREML2	8.40e-04	163	47	4	590
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	DNAJB12 DNAJB14	7.20e-03	49	47	2	584
GeneFamily	Olfactory receptors, family 6	OR6T1 OR6P1	7.78e-03	51	47	2	153
GeneFamily	Immunoglobulin like domain containing	SLAMF8 CD244 PDGFRB	1.38e-02	193	47	3	594
GeneFamily	Short chain dehydrogenase/reductase superfamily	HSD17B13 NSDHL	1.67e-02	76	47	2	743
GeneFamily	Solute carriers	RHCG SLC10A5 SLC38A5 SLC38A3	1.91e-02	395	47	4	752
Coexpression	FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP	TLR10 CCR2 FCER1G CCR5	2.28e-06	46	53	4	M40885
Coexpression	FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP	TLR10 CCR2 FCER1G CCR5	5.43e-06	57	53	4	M40884
Coexpression	FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP	TLR10 CCR2 FCER1G CCR5	6.68e-06	60	53	4	M40883
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_DN	CCR2 IFITM3 FPR1 TMEM154 HID1 DNAJB14	1.96e-05	276	53	6	M8646
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_D_DN	CCR2 IFITM3 FPR1 TMEM154 HID1 DNAJB14	3.24e-05	302	53	6	MM1046
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_UP	FCER1G CD244 IFITM3 TMEM154 CCR5 IFITM2	4.25e-05	317	53	6	M2086
Coexpression	ZHONG_PFC_MAJOR_TYPES_ASTROCYTES	ADORA2B PDGFRB IFITM3 MRC2 LRP4 SLC38A3	4.96e-05	326	53	6	M39074
Coexpression	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	VRK2 IFITM3 TMEM154 IFITM2 ATP10D	5.12e-05	199	53	5	M3311
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_UP	SLAMF8 FCER1G IFITM3 LRP4 IFITM2	5.24e-05	200	53	5	M3584
Coexpression	GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN	CCR2 IFITM3 LRP4 IFITM2 HID1	5.24e-05	200	53	5	M6570
Coexpression	GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP	CCR2 IFITM3 CCR5 IFITM2 HID1	5.24e-05	200	53	5	M9286
Coexpression	GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP	CCR2 IFITM3 CCR5 IFITM2 HID1	5.24e-05	200	53	5	M9284
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	CCR2 TMEM154 CD79B CCR5 ATP10D	5.24e-05	200	53	5	M9181
Coexpression	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	CCR2 FCER1G CD244 IFITM3 CCR5	5.24e-05	200	53	5	M3036
Coexpression	GSE10325_BCELL_VS_MYELOID_DN	CCR2 ADORA2B CD244 FPR1 CCR5	5.24e-05	200	53	5	M3082
Coexpression	LI_INDUCED_T_TO_NATURAL_KILLER_UP	FCER1G CD244 IFITM3 TMEM154 CCR5 IFITM2	6.57e-05	343	53	6	MM1059
Coexpression	KAAB_FAILED_HEART_VENTRICLE_DN	FCER1G IFITM3 IFITM2	9.75e-05	44	53	3	M15188
Coexpression	FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP	TLR10 CCR2 CCR5	1.04e-04	45	53	3	M40886
Coexpression	HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP	SLAMF8 CCR2 VRK2 FCER1G IFITM3 FPR1	1.10e-04	377	53	6	M40997
Coexpression	DESCARTES_FETAL_PANCREAS_MYELOID_CELLS	SLAMF8 CCR2 FCER1G FPR1 CCR5	1.17e-04	237	53	5	M40264
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	FCER1G IFITM3 IFITM2	1.43e-04	50	53	3	MM3805
Coexpression	ROETH_TERT_TARGETS_DN	CCR2 CCR5	1.43e-04	9	53	2	M2891
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	FCER1G IFITM3 IFITM2	1.61e-04	52	53	3	MM3808
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP	SLAMF8 CCR2 ZDHHC11B VRK2 FCER1G IFITM3 FPR1 SLC38A5 IFITM2	1.77e-04	1012	53	9	M40868
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP	VRK2 IFITM3 IFITM2	1.90e-04	55	53	3	M40901
Coexpression	SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP	VRK2 IFITM3 IFITM2	1.90e-04	55	53	3	M40900
Coexpression	MCLACHLAN_DENTAL_CARIES_UP	SLAMF8 C1QL1 CCR2 FCER1G FPR1	1.96e-04	265	53	5	M10454
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	CCR2 VRK2 FCER1G CD244 IFITM3 CD79B CCR5	2.29e-04	615	53	7	MM3641
Coexpression	GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP	CCR2 PDGFRB LMBR1 DSG4	2.31e-04	148	53	4	M348
Coexpression	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP	PDGFRB CD79B DSG4 SLC38A3	2.37e-04	149	53	4	M2908
Coexpression	SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP	SLAMF8 VRK2 IFITM3 FPR1 IFITM2	2.75e-04	285	53	5	M40879
Coexpression	DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS	PDGFRB IFITM3 OR9Q1 SLC38A5 CD79B IFITM2 SLC38A3	3.05e-04	645	53	7	M40158
Coexpression	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP	CCR2 FPR1 TREML2 NSDHL	3.33e-04	163	53	4	M6763
Coexpression	NABA_ECM_AFFILIATED	C1QL1 C1QL3 C1QL4 MUC12	3.90e-04	170	53	4	M5880
Coexpression	BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	FCER1G IFITM3 FPR1 IFITM2	4.26e-04	174	53	4	M34028
Coexpression	FAN_EMBRYONIC_CTX_ASTROCYTE_1	ADORA2B MRC2 LRP4	5.54e-04	79	53	3	M39033
Coexpression	GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN	RNLS ATP10B CCR5 NSDHL	6.67e-04	196	53	4	M3135
Coexpression	GSE22886_TCELL_VS_BCELL_NAIVE_DN	CD79B ATP10D TREML2 PGR	6.93e-04	198	53	4	M4426
Coexpression	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	CCR2 IFITM3 CD79B IFITM2	7.06e-04	199	53	4	M8100
Coexpression	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	VRK2 IFITM3 IFITM2 ATP10D	7.06e-04	199	53	4	M3286
Coexpression	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	GABRE IFITM2 STX16 BTN2A1	7.06e-04	199	53	4	M3460
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN	FCER1G CD244 ERMAP IFITM2	7.06e-04	199	53	4	M5585
Coexpression	GSE3982_EOSINOPHIL_VS_BCELL_UP	ADORA2B CD244 FPR1 MMP15	7.06e-04	199	53	4	M5406
Coexpression	GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP	C1QL1 GABRE IFITM3 SLC38A3	7.06e-04	199	53	4	M3918
Coexpression	KIM_GLIS2_TARGETS_UP	CCR2 FCER1G IFITM3	7.10e-04	86	53	3	M2259
Coexpression	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	SLAMF8 FCER1G PDGFRB MRC2 ATP10D	7.18e-04	352	53	5	M17471
Coexpression	GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN	FCER1G CD244 CCR5 HID1	7.19e-04	200	53	4	M5045
Coexpression	GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN	CCR2 IFITM3 IFITM2 BTN2A1	7.19e-04	200	53	4	M4632
Coexpression	GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN	FCER1G CD79B IFITM2 HID1	7.19e-04	200	53	4	M9302
Coexpression	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	VRK2 IFITM3 CCR5 IFITM2	7.19e-04	200	53	4	M3288
Coexpression	GSE13306_RA_VS_UNTREATED_TCONV_DN	CCR2 IFITM3 FPR1 IFITM2	7.19e-04	200	53	4	M3235
Coexpression	GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN	GABRE IFITM2 BCL2L13 BTN2A1	7.19e-04	200	53	4	M9597
Coexpression	GSE28408_LY6G_POS_VS_NEG_DC_DN	CD244 PDGFRB IFITM3 CCR5	7.19e-04	200	53	4	M9545
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	VRK2 IFITM3 IFITM2 BCL2L13	7.19e-04	200	53	4	M9572
Coexpression	GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN	SLAMF8 RHCG VRK2 LRP4	7.19e-04	200	53	4	M7814
Coexpression	GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN	CCR2 SLC38A5 CCR5 IFITM2	7.19e-04	200	53	4	M3676
Coexpression	GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP	TMEM154 LRP4 FFAR4 TREML2	7.19e-04	200	53	4	M9299
Coexpression	GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN	CD244 HID1 STX16 FFAR4	7.19e-04	200	53	4	M6187
Coexpression	GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN	FCER1G IFITM3 FPR1 IFITM2	7.19e-04	200	53	4	M4482
Coexpression	KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP	CCR2 CD244 IFITM3 CD79B	7.19e-04	200	53	4	M3030
Coexpression	KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD	CCR2 CCR5	8.22e-04	21	53	2	M1986
Coexpression	FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL	PDGFRB IFITM3 SLC38A5 IFITM2 SLC38A3	8.45e-04	365	53	5	M39018
CoexpressionAtlas	Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2 DNAJB14 FFAR4	3.33e-07	407	49	9	GSM538245_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2 DNAJB14	3.79e-06	406	49	8	GSM854273_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2	SLAMF8 CCR2 ADORA2B FCER1G CD244 IFITM3 CCR5 IFITM2	4.30e-06	413	49	8	GSM605878_500
CoexpressionAtlas	appendix	TLR10 SLAMF8 CCR2 FPR1 CD79B TREML2	4.82e-06	190	49	6	appendix
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2 DNAJB14	5.39e-06	426	49	8	GSM605859_500
CoexpressionAtlas	B cells, B.Pl.AA4+220+.BM, CD138+ AA4.1+ CD43- CD45R+, Bone marrow, avg-3	CCR2 FCER1G CD244 IFITM3 FPR1 CD79B IFITM2	1.15e-05	337	49	7	GSM777024_500
CoexpressionAtlas	Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	1.34e-05	345	49	7	GSM854324_500
CoexpressionAtlas	Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2	CCR2 FCER1G IFITM3 CCR5	1.44e-05	64	49	4	GSM854322_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3	CCR2 FCER1G CD244 IFITM3	1.94e-05	69	49	4	GSM605872_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4	CCR2 FCER1G CD244 IFITM3	2.17e-05	71	49	4	GSM605868_100
CoexpressionAtlas	NK cells, NK.DAP10-.Sp, NK1.1+ TCRb-, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.17e-05	71	49	4	GSM538294_100
CoexpressionAtlas	NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.17e-05	71	49	4	GSM538288_100
CoexpressionAtlas	NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.17e-05	71	49	4	GSM538285_100
CoexpressionAtlas	NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.29e-05	72	49	4	GSM605814_100
CoexpressionAtlas	NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.29e-05	72	49	4	GSM538312_100
CoexpressionAtlas	Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2	CCR2 FCER1G IFITM3 IFITM2	2.29e-05	72	49	4	GSM854320_100
CoexpressionAtlas	Myeloid Cells, DC.11cloSer.SI, CD45+ MHCII+ CD11c-lo CD11b+, Small Intestine, avg-5	SLAMF8 CCR2 FCER1G IFITM3 FPR1 CCR5 IFITM2	2.38e-05	377	49	7	GSM854280_500
CoexpressionAtlas	NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.42e-05	73	49	4	GSM538309_100
CoexpressionAtlas	NK cells, NK.Sp, NK1.1+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.42e-05	73	49	4	GSM538315_100
CoexpressionAtlas	NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.42e-05	73	49	4	GSM538291_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3	CCR2 FCER1G IFITM3 CCR5	2.42e-05	73	49	4	GSM854273_100
CoexpressionAtlas	NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.56e-05	74	49	4	GSM538297_100
CoexpressionAtlas	Myeloid Cells, DC.4+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	SLAMF8 CCR2 FCER1G IFITM3	2.56e-05	74	49	4	GSM538245_100
CoexpressionAtlas	NK cells, NK.49H-.Sp, NK1.1+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.56e-05	74	49	4	GSM605817_100
CoexpressionAtlas	NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	CCR2 FCER1G CD244 CCR5	2.70e-05	75	49	4	GSM538303_100
CoexpressionAtlas	Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	2.72e-05	385	49	7	GSM854315_500
CoexpressionAtlas	Myeloid Cells, MF.Medl.SLN, CD11b+ CD169+ F4/80+, Lymph Node, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	3.00e-05	391	49	7	GSM854322_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2 DNAJB14	3.20e-05	395	49	7	GSM538265_500
CoexpressionAtlas	Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	3.58e-05	402	49	7	GSM854320_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	3.70e-05	404	49	7	GSM854269_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-1	SLAMF8 CCR2 VRK2 FCER1G IFITM3 IFITM2 FFAR4	3.87e-05	407	49	7	GSM854287_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4	SLAMF8 CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	3.93e-05	408	49	7	GSM605868_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	SLAMF8 CCR2 VRK2 CD244 IFITM3 CCR5 FFAR4	4.00e-05	409	49	7	GSM538234_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3	SLAMF8 CCR2 FCER1G CD244 IFITM3 FPR1 IFITM2	4.00e-05	409	49	7	GSM854332_500
CoexpressionAtlas	Myeloid Cells, GN.UrAc.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3	FCER1G CD244 IFITM3 FPR1 TMEM154 IFITM2 TREML2	4.06e-05	410	49	7	GSM854312_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3	CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2 DNAJB14	4.12e-05	411	49	7	GSM605872_500
CoexpressionAtlas	alpha beta T cells, preT.ETP-2A.Th, Lin-/lo CD25int CD44+ cKit+, Thymus, avg-2	CD244 PDGFRB IFITM3 IFITM2	4.42e-05	85	49	4	GSM791152_100
CoexpressionAtlas	alpha beta T cells, preT.ETP.Th, Lin-/lo CD25- CD44+ cKit+, Thymus, avg-3	CD244 PDGFRB IFITM3 IFITM2	4.62e-05	86	49	4	GSM854335_100
CoexpressionAtlas	Myeloid Cells, DC.8+.SLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	SLAMF8 CCR2 VRK2 CD244 CCR5 DNAJB14 FFAR4	5.09e-05	425	49	7	GSM538255_500
CoexpressionAtlas	Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4	SLAMF8 FCER1G IFITM3 FPR1 CCR5 IFITM2	1.83e-04	364	49	6	GSM854276_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3	SLAMF8 CCR2 VRK2 FCER1G IFITM3 IFITM2	1.88e-04	366	49	6	GSM854255_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4	SLAMF8 FCER1G IFITM3 FPR1 CCR5 IFITM2	1.94e-04	368	49	6	GSM854258_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	2.12e-04	374	49	6	GSM605875_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Spleen, avg-2	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	2.15e-04	375	49	6	GSM605837_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5	SLAMF8 FCER1G CD244 IFITM3 CCR5 IFITM2	2.27e-04	379	49	6	GSM854232_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7	SLAMF8 FCER1G CD244 IFITM3 CCR5 IFITM2	2.34e-04	381	49	6	GSM854262_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1	SLAMF8 VRK2 FCER1G CD244 IFITM3 IFITM2	2.41e-04	383	49	6	GSM605826_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3	CCR2 CD244 IFITM3 CCR5 IFITM2 FFAR4	2.44e-04	384	49	6	GSM605820_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-3	SLAMF8 VRK2 FCER1G CD244 IFITM3 IFITM2	2.69e-04	391	49	6	GSM538249_500
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3	SLAMF8 CCR2 FCER1G IFITM3 FPR1 IFITM2	2.69e-04	391	49	6	GSM854329_500
CoexpressionAtlas	gamma delta T cells, Tgd.Sp, TCRd+ CD3e+, Spleen, avg-3	FCER1G CD244 IFITM3 C1QL3 FPR1 HID1	2.76e-04	393	49	6	GSM476672_500
CoexpressionAtlas	B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R+ CD117+ IL7R+, Bone marrow, avg-1	FCER1G CD244 PDGFRB IFITM3 FPR1 TMEM154	2.84e-04	395	49	6	GSM538351_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5	CCR2 FCER1G CD244 IFITM3 FPR1 IFITM2	3.04e-04	400	49	6	GSM605886_500
CoexpressionAtlas	Myeloid Cells, MF.BM, B220neg CD3neg Ly-6C/Glo CD115int F4/80+, Bone marrow, avg-3	FCER1G PDGFRB IFITM3 ERMAP SLC38A5 IFITM2	3.08e-04	401	49	6	GSM854317_500
CoexpressionAtlas	NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3	CCR2 FCER1G CD244 C1QL3 CCR5 HID1	3.12e-04	402	49	6	GSM538297_500
CoexpressionAtlas	NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3	CCR2 FCER1G CD244 C1QL3 CCR5 HID1	3.16e-04	403	49	6	GSM605814_500
CoexpressionAtlas	Myeloid Cells, DC.8+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-2	SLAMF8 CCR2 VRK2 CD244 IFITM3 FFAR4	3.33e-04	407	49	6	GSM538258_500
CoexpressionAtlas	Myeloid Cells, GN.Bl, CD11b+ Ly6-G+, Blood, avg-3	FCER1G CD244 IFITM3 FPR1 TMEM154 IFITM2	3.42e-04	409	49	6	GSM854306_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3	CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	3.42e-04	409	49	6	GSM605823_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg5+.act.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44hi, Small Intestine, avg-3	FCER1G CD244 TMEM154 CD79B CCR5 NSDHL	3.46e-04	410	49	6	GSM605802_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	SLAMF8 CCR2 FCER1G IFITM3 CCR5 IFITM2	3.51e-04	411	49	6	GSM538239_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.Sp, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Spleen, avg-1	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	3.55e-04	412	49	6	GSM605839_500
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2	SLAMF8 CCR2 FCER1G IFITM3 CCR5 IFITM2	3.65e-04	414	49	6	GSM854271_500
CoexpressionAtlas	Myeloid Cells, GN.Thio.PC, CD11b+ Ly6-G+, Peritoneal Cavity, avg-3	FCER1G IFITM3 FPR1 TMEM154 IFITM2 TREML2	3.74e-04	416	49	6	GSM854309_500
CoexpressionAtlas	Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2	CCR2 FCER1G IFITM3	3.78e-04	61	49	3	GSM854324_100
CoexpressionAtlas	Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	SLAMF8 VRK2 CD244 IFITM3 CCR5 FFAR4	3.94e-04	420	49	6	GSM538252_500
CoexpressionAtlas	Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3	SLAMF8 CCR2 FCER1G IFITM3 CCR5 IFITM2	4.14e-04	424	49	6	GSM854294_500
CoexpressionAtlas	Myeloid Cells, MF.169+11chi.SLN, CD11b+ CD169+ CD11chigh, Lymph Node, avg-2	CCR2 FCER1G IFITM3	4.77e-04	66	49	3	GSM854315_100
CoexpressionAtlas	Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3	FCER1G CD244 IFITM3 FPR1 CCR5 IFITM2	4.91e-04	438	49	6	GSM605850_500
CoexpressionAtlas	Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5	FCER1G CD244 IFITM3	4.99e-04	67	49	3	GSM605886_100
CoexpressionAtlas	Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3	CCR2 FCER1G IFITM3	5.44e-04	69	49	3	GSM854329_100
CoexpressionAtlas	Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3	FCER1G CD244 IFITM3	5.67e-04	70	49	3	GSM605883_100
CoexpressionAtlas	Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2	CCR2 FCER1G IFITM3	5.91e-04	71	49	3	GSM605878_100
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	CCR2 IFITM3 CCR5	6.16e-04	72	49	3	GSM605859_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d100.LisOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	6.41e-04	73	49	3	GSM605904_100
CoexpressionAtlas	Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3	FCER1G IFITM3 IFITM2	6.67e-04	74	49	3	GSM854332_100
CoexpressionAtlas	NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3	FCER1G CD244 CCR5	6.94e-04	75	49	3	GSM538300_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2	CCR2 CCR5 HID1	6.94e-04	75	49	3	GSM538385_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	7.21e-04	76	49	3	GSM538403_100
CoexpressionAtlas	Myeloid Cells, GN.Arth.SynF, CD11b+ Ly6-G+, Synovial Fluid, avg-3	IFITM3 FPR1 IFITM2	7.21e-04	76	49	3	GSM854338_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	7.49e-04	77	49	3	GSM605901_100
CoexpressionAtlas	Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3	CCR2 IFITM3 CCR5	7.49e-04	77	49	3	GSM854294_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	7.49e-04	77	49	3	GSM538392_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	7.49e-04	77	49	3	GSM605894_100
CoexpressionAtlas	alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3	CCR2 CCR5 HID1	7.78e-04	78	49	3	GSM605891_100
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp.OT1.d45.LisOva, CD8+ CD45.1+, Spleen, avg-2	CCR2 CCR5 HID1	7.78e-04	78	49	3	GSM605907_100
CoexpressionAtlas	alpha beta T cells, NKT.4-.Sp, TCRbeta+ aGalCer tet+ CD4-, Spleen, avg-3	CCR2 TMEM154 CCR5	7.78e-04	78	49	3	GSM538329_100
CoexpressionAtlas	B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1	PDGFRB IFITM3 FPR1	8.07e-04	79	49	3	GSM538343_100
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	CCR2 IFITM3 CCR5	8.37e-04	80	49	3	GSM605856_100
CoexpressionAtlas	alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4	CCR2 TMEM154 CCR5	8.68e-04	81	49	3	GSM538318_100
CoexpressionAtlas	Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3	CCR2 FCER1G IFITM3	9.00e-04	82	49	3	GSM791114_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	CCR2 FCER1G IFITM3	1.03e-03	86	49	3	GSM538239_100
CoexpressionAtlas	B cells, proB.CLP.BM, AA4.1+ CD117+ IL7R+ CD45R- CD24- CD19- IgM-, Bone marrow, avg-1	FCER1G CD244 PDGFRB IFITM3 FPR1	1.07e-03	338	49	5	GSM538347_500
CoexpressionAtlas	NK cells, NK.DAP10-.Sp, NK1.1+ TCRb-, Spleen, avg-3	CCR2 FCER1G CD244 C1QL3 CCR5	1.15e-03	344	49	5	GSM538294_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#4_top-relative-expression-ranked_100	ADORA2B SLC38A5	1.28e-03	23	49	2	gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k4
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.SI, CD45+ MHCII+ CD11c-hi CD103+ CD11b-, Small Intestine, avg-4	SLAMF8 CD244 IFITM3 CCR5 FFAR4	1.63e-03	372	49	5	GSM854251_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103+ F4/80-lo, Small Intestine, avg-4	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.69e-03	375	49	5	GSM854237_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b+.Sp, CD11b CD11c CD45 CD8a CD4, Spleen, avg-2	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.71e-03	376	49	5	GSM538266_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3	CCR2 CD244 C1QL3 CCR5 HID1	1.73e-03	377	49	5	GSM476681_500
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.83e-03	382	49	5	GSM538248_500
ToppCell	Lymphoid-Lymphoid-NK_cells\|Lymphoid / shred on cell class and cell subclass (v4)	CCR2 FCER1G CD244 IFITM3 CCR5 IFITM2	2.90e-08	148	55	6	d51a4b654a88d58dcdf29c2bc362c0cc1c40723a
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	VRK2 FCER1G IFITM3 MRC2 PIGW IFITM2	3.40e-08	152	55	6	18194f757d319958f26e5a91f56d89f25711236f
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 FPR1 FFAR4	3.68e-08	154	55	6	ad6cfd7fc02f4201863dc8e12e353395c86c5fdb
ToppCell	droplet-Kidney-nan-18m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 FPR1 FFAR4	4.29e-08	158	55	6	e0b862e4b9ebaa12869640b5d18d5fa852861bef
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 VRK2 FCER1G CD244 FFAR4	4.62e-08	160	55	6	5c28121916a12dbc22ef2421040bdc9148a40b78
ToppCell	droplet-Kidney-nan-3m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 VRK2 FCER1G CD244 FFAR4	4.62e-08	160	55	6	b7093678987575f2f99d648821d31b4a37075aca
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 VRK2 FCER1G CD244 FPR1 FFAR4	4.62e-08	160	55	6	741e3b3f4ec5c77752da54746451f332435226e3
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 CD244 IFITM3 FPR1 IFITM2 FFAR4	4.62e-08	160	55	6	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	droplet-Kidney-nan-24m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 FPR1	5.35e-08	164	55	6	d0b6c29e61d15f4dbe4c1f6e5ed3e10f41f820ab
ToppCell	droplet-Kidney-nan-24m-Myeloid\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 FPR1	5.35e-08	164	55	6	718cc64b7ef7d03d095be4b2b54c449154da568c
ToppCell	droplet-Spleen-nan-18m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	5.75e-08	166	55	6	e841e62cb20235d6233f78f4155fb8c0ffb1ef1b
ToppCell	droplet-Spleen-nan-18m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	5.75e-08	166	55	6	3ca3ddb663644f0e7f70f9b75833bb54cd9191d3
ToppCell	droplet-Spleen-nan-18m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	5.75e-08	166	55	6	f751cbd01d4978ded7755874ab60504f6291afd7
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.17e-08	168	55	6	f3b7a7df54988de77dcc7066e2fc1feb9c280b13
ToppCell	droplet-Spleen-nan-3m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.40e-08	169	55	6	91cfff1ad559cc327c6bb71c98aa29f0b3642568
ToppCell	droplet-Spleen-nan-3m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.40e-08	169	55	6	8e5e513090e86ca29fb61dfd388014774c506914
ToppCell	droplet-Spleen-nan-3m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.40e-08	169	55	6	972618e684321060c7af2429f853a6d639e8aae8
ToppCell	droplet-Fat-Scat\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B FCER1G IFITM3 CCR5 IFITM2	6.62e-08	170	55	6	de722bea7527d6ad11b69f8e9589638f52854beb
ToppCell	droplet-Spleen-nan-21m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B FCER1G IFITM3 IFITM2 PGR	6.62e-08	170	55	6	03cb4e508356f85372a588c8d1c6babf2a012683
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.62e-08	170	55	6	7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1
ToppCell	droplet-Spleen-SPLEEN-1m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.62e-08	170	55	6	db7cee7e518debb2cbe9eeae05d47e14b69cb8e3
ToppCell	droplet-Spleen-nan-21m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B FCER1G IFITM3 IFITM2 PGR	6.86e-08	171	55	6	9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753
ToppCell	droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLAMF8 CCR2 FCER1G CD244 IFITM3 IFITM2	6.86e-08	171	55	6	ed5886d6aa87b2d73469d39dc217227bd4d4c918
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2 FFAR4	6.86e-08	171	55	6	4a2e6ea9674bf23e8012ef0bb2bf19ce1f55fcd5
ToppCell	droplet-Spleen-nan-21m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B FCER1G IFITM3 IFITM2 PGR	6.86e-08	171	55	6	db544252f98e073e5bb4bec4a110cd58e6434435
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2 FFAR4	6.86e-08	171	55	6	35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd
ToppCell	droplet-Spleen-nan-21m-Myeloid-macrophage\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2 FFAR4	7.10e-08	172	55	6	4fe5b91e4871bc6c5be57eb5b8bb04815b2fb80d
ToppCell	droplet-Spleen-nan-18m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2 FFAR4	7.10e-08	172	55	6	850e4c9e9003807c19695be4b13121b0808a9389
ToppCell	droplet-Spleen-nan-18m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2 FFAR4	7.10e-08	172	55	6	018d8160cfcb7882475620dc678f48a69a0f643e
ToppCell	droplet-Spleen-nan-24m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B FCER1G PDGFRB IFITM3 IFITM2	8.41e-08	177	55	6	5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff
ToppCell	PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TLR10 CCR2 FCER1G CD244 CCR5 TREML2	9.60e-08	181	55	6	f737f2b1f35747b81fdd8996e289bde5c290af61
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCER1G IFITM3 FPR1 IFITM2 PANX2 TREML2	9.92e-08	182	55	6	f9c013075477e77a8373c73301a51e7e3f35369c
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TLR10 SLAMF8 CCR2 FCER1G FPR1 FFAR4	1.02e-07	183	55	6	9840706f972387241bf1d4ba8af25efc3214a91b
ToppCell	cellseq2-Immune-Immune_Myeloid-Myeloid_Dendritic\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TLR10 SLAMF8 CCR2 FCER1G FPR1 FFAR4	1.02e-07	183	55	6	409cb52cf4c967e52bf75a6680bcbe87f638c75d
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FCER1G IFITM3 FPR1 TMEM154 IFITM2 PANX2	1.16e-07	187	55	6	75bc05a0ba2727fecc236903ace792a28f3d3c9a
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_0\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FCER1G IFITM3 FPR1 TMEM154 IFITM2 PANX2	1.16e-07	187	55	6	a0d59bf1043ff5a1e8110b39ecc2d3932675edd4
ToppCell	Hippocampus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 CD79B CCR5 TREML2	1.21e-07	95	55	5	6122a821dd1d1630ce11d219dcde6bd74e5487d1
ToppCell	Hippocampus-Hematopoietic-MICROGLIA-MI2(C1qb)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 CD79B CCR5 TREML2	1.21e-07	95	55	5	8f058263d52099544488bd4ee1850d97dfd33de4
ToppCell	Hippocampus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 CD79B CCR5 TREML2	1.21e-07	95	55	5	ac03599e8e16465dbede1ce5c6a4176246d79fa1
ToppCell	Hippocampus-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 CD79B CCR5 TREML2	1.21e-07	95	55	5	d5f5af5bf542a72a4f9dba05277824b5c8b2fb6d
ToppCell	Hippocampus-Hematopoietic-MICROGLIA\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 CD79B CCR5 TREML2	1.21e-07	95	55	5	aa217fa29152df1dbc54d33f36e3f288a18ef417
ToppCell	MNPs-Monocytes\|MNPs / lung cells shred on cell class, cell subclass, sample id	CCR2 IFITM3 FPR1 TMEM154 CD79B IFITM2	1.49e-07	195	55	6	45e8d27287bdfd07d7e944ae5d3f44d05c33468f
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	ADORA2B PDGFRB IFITM3 MRC2 LRP4 SLC38A3	1.73e-07	200	55	6	29f82e2ad2f1888b6b236a4392b88a84351b8ddc
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	ADORA2B PDGFRB IFITM3 MRC2 LRP4 SLC38A3	1.73e-07	200	55	6	1598a9e8efa72fda7d12df07e7716b326cdf1d5e
ToppCell	frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-OPC_Pdgfra_Grm5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	C1QL1 ADORA2B LRP4 MMP15 SLC38A3	6.47e-07	133	55	5	63d2f096ae47d9b587acc6c5fbd346e5e58842b8
ToppCell	Cerebellum-Hematopoietic-MICROGLIA\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	75cca1e6c1af289987d5d98455e9c6db81ecdd64
ToppCell	Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	a077ce50f6d6746d80de35abed5b6dc35b1145b9
ToppCell	Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	de34e2f51f6fda638357abb662c111a20b83e70b
ToppCell	Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	0ae117308bd10d3a7d2688794c69dc5a31cfca5f
ToppCell	Cerebellum-Hematopoietic-MICROGLIA-MI1(C1qb)-MICROGLIA_Microglia.C1qb.Mrc1-Tmem119_(Resident_macrophage)--\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	fac6a3100a277efa1db250e0c576be1a0c901e6d
ToppCell	Cerebellum-Hematopoietic\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SLAMF8 CCR2 FPR1 CD79B CCR5	8.04e-07	139	55	5	3913c3828ad4cb5c71380519d0cf5f195e53c51d
ToppCell	Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLAMF8 FCER1G FPR1 CD79B CCR5	8.33e-07	140	55	5	8db98a17a4d4b42dbfc75e9cdaa22275fed4f2f0
ToppCell	Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLAMF8 FCER1G FPR1 CD79B CCR5	8.33e-07	140	55	5	22098203361f61b9f0ce9f0f2d1369d8bb1379a8
ToppCell	Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLAMF8 FCER1G FPR1 CD79B CCR5	8.33e-07	140	55	5	2c04fa782aa076e4be8a2781aa04231180bd69bd
ToppCell	Frontal_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia.C1qb.Tmem119-Fos)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLAMF8 FCER1G FPR1 CD79B CCR5	8.33e-07	140	55	5	a9389a6e55d02d5037868c9ecce48b5e8d7c2902
ToppCell	P03-Hematopoietic\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCR2 FCER1G CD244 ERMAP TREML2	8.63e-07	141	55	5	4a856521520ea73291f4730fe94c5de88c2b6f0c
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCER1G IFITM3 FPR1 TMEM154 IFITM2	8.63e-07	141	55	5	9f26b2a5ccdf8762f16b673e59543b694fbacc10
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCER1G IFITM3 FPR1 TMEM154 IFITM2	9.25e-07	143	55	5	5d5ba2717126a0d4e4464f3604cb282cb977d5b2
ToppCell	facs-Marrow-T-cells-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 IFITM2	9.91e-07	145	55	5	4f8b188a93a038afbc7a446df8467ad544f5b1cb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 IFITM2	1.25e-06	152	55	5	d279592c501fca9cb474ad916fea32282e6969cb
ToppCell	facs-Marrow-T-cells-24m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 IFITM2	1.25e-06	152	55	5	3b59143b2b4ee24eb6378f87ff568124193256e9
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCR2 ADORA2B IFITM3 FPR1 IFITM2	1.29e-06	153	55	5	0ef7c45cdd854c79e527006034029767f8e108b2
ToppCell	P28-Hematopoietic\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCR2 FCER1G FPR1 CD79B TREML2	1.33e-06	154	55	5	13980ae1957b05350c11171c9c118decfe998d3d
ToppCell	P28-Hematopoietic-Immune-immune_cell_unspecified\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCR2 FCER1G FPR1 CD79B TREML2	1.47e-06	157	55	5	a70f93aff07b6b7a9efce33b12b024116648dc0a
ToppCell	P28-Hematopoietic-Immune\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CCR2 FCER1G FPR1 CD79B TREML2	1.47e-06	157	55	5	b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCER1G IFITM3 FPR1 TMEM154 IFITM2	1.47e-06	157	55	5	0673c7161c25feceee8f1e5fd237171576c42c6b
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCER1G IFITM3 FPR1 TMEM154 IFITM2	1.47e-06	157	55	5	d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0
ToppCell	PND10-Immune-Immune_Myeloid-DC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLAMF8 CCR2 FCER1G CCR5 FFAR4	1.47e-06	157	55	5	ed387cf06d19e201a2a0dc4f3c796fcf8fa6637a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCER1G IFITM3 FPR1 TMEM154 IFITM2	1.56e-06	159	55	5	6c0ef40f64d2e35eaae3d0002e3c1f22d1239736
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CCR5 FFAR4	1.56e-06	159	55	5	3bab00f8fb7d9232538e50f83dd0fd70ddd16819
ToppCell	droplet-Kidney-nan-3m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G IFITM3 CCR5 STX16	1.56e-06	159	55	5	bea6e96ba40ebfc1e38687bfa1c61fe227c5a84d
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-cardiac_mast_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCER1G CD244 FPR1 TMEM154 TREML2	1.56e-06	159	55	5	766dfb9f9c0783e740a4fd395e99669310b33371
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FCER1G IFITM3 FPR1 TMEM154 IFITM2	1.56e-06	159	55	5	745a59c33b04620c5329bdd50e74a8e611f2dc55
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 FCER1G CD244 CCR5 PGR	1.61e-06	160	55	5	b2d8940ea8c068273b7da1589d3d6ae5110d8209
ToppCell	droplet-Kidney-nan-18m-Myeloid-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.61e-06	160	55	5	d18c4cc99a31481dd0ee8af9299695d5f6857b42
ToppCell	Frontal_cortex-Hematopoietic\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SLAMF8 FCER1G FPR1 CD79B CCR5	1.61e-06	160	55	5	70ffbe61cfd729519b23569a43d929b117ab8d5e
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 FCER1G CD244 CCR5 PGR	1.61e-06	160	55	5	9caab1bb63c7e66c44783852ee75b16bb40fa594
ToppCell	droplet-Kidney-nan-18m-Myeloid\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.61e-06	160	55	5	a707a4ad9fbedcca227f76b49f1393e88101c2fb
ToppCell	droplet-Kidney-nan-18m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.61e-06	160	55	5	73b604cbdcd9e8f0f317964abc632abee314a557
ToppCell	droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l1-4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLAMF8 CCR2 ADORA2B FCER1G CD244	1.61e-06	160	55	5	6329b0f02f9509086e563c2ed762a8ec693883b5
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 FCER1G CD244 CCR5 PGR	1.61e-06	160	55	5	229841be7b984a00a301cd5d88c11226a90d8a88
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CCR5 FFAR4	1.61e-06	160	55	5	5bec867def73fa8531f8dad611679f4b44f573bd
ToppCell	E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCR2 FCER1G CD244 CCR5 PGR	1.61e-06	160	55	5	99c9ae2041445539fada842e1af01368669bfca0
ToppCell	facs-Spleen-nan-3m-Hematologic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.66e-06	161	55	5	45591addc765760db6029ac19e80573373d1d917
ToppCell	facs-Spleen-nan-3m-Hematologic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.66e-06	161	55	5	8741b91a62c9a8ce377ef6533d323b65beb93c63
ToppCell	facs-Spleen-nan-3m-Hematologic-proerythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G CD244 IFITM3 IFITM2	1.66e-06	161	55	5	9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.71e-06	162	55	5	4c6e0cadd0ff50b0f50e0cfdc9027210e72674b9
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.71e-06	162	55	5	db1e09324e9fdd5e571600cff4f2b1c0cb3c179d
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.71e-06	162	55	5	9734943c8b7c04e568792253b7352672a3a5cc58
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.71e-06	162	55	5	48d7bee271f74b5d06c03c6ae06a662d765a6de3
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid-macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.82e-06	164	55	5	e19fc6ba049336ab989a3a968bdbefd567971d73
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.82e-06	164	55	5	d6526551d0b183c3ef027ba3dbfddeac03fd93bb
ToppCell	droplet-Spleen-nan-24m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCER1G IFITM3 ERMAP SLC38A5 IFITM2	1.82e-06	164	55	5	4d8233f69ea89d4104caa56bdd0c23c27cabe9b3
ToppCell	droplet-Limb_Muscle-nan-24m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.82e-06	164	55	5	b1a6f56207cb0fbd3f99225d4a7354a17aa26362
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G IFITM3 CCR5	1.82e-06	164	55	5	eba25e4d65ca66b5192a7a4d11423f3fa0956828
ToppCell	droplet-Limb_Muscle-nan-24m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 CCR5	1.82e-06	164	55	5	f3684d029ca58b782e3e87f79e56069b42b22fdd
ToppCell	droplet-Kidney-nan-24m-Myeloid-CD45____macrophage\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 CCR2 FCER1G CD244 FPR1	1.82e-06	164	55	5	d57faa4fce1f1e9a92aaf5cb920af99323252e4b
ToppCell	droplet-Spleen-nan-21m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G IFITM3 IFITM2 FFAR4	1.87e-06	165	55	5	fbd84f211ad645c91b9f45a0815391606f3206ac
ToppCell	droplet-Spleen-nan-21m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLAMF8 FCER1G IFITM3 IFITM2 FFAR4	1.87e-06	165	55	5	6fbdfacb49e627712ac999d40ae22dcb390edd3e
ToppCell	droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCER1G IFITM3 FPR1 LRP4 IFITM2	1.87e-06	165	55	5	b671c6a950e70f64776c2104baccb3dc2bb6a1ba
Computational	Genes in the cancer module 128.	CCR2 FCER1G PDGFRB IFITM3 FPR1 CCR5 IFITM2	8.62e-09	97	31	7	MODULE_128
Computational	Genes in the cancer module 79.	CCR2 FCER1G PDGFRB IFITM3 FPR1 CCR5 IFITM2	9.95e-09	99	31	7	MODULE_79
Computational	Immune response.	CCR2 FCER1G PDGFRB IFITM3 FPR1 CCR5 IFITM2	1.07e-08	100	31	7	MODULE_170
Computational	Genes in the cancer module 292.	IFITM3 FPR1 CD79B IFITM2 UNC79	3.93e-05	136	31	5	MODULE_292
Computational	Genes in the cancer module 27.	GABRE CCR2 FCER1G PDGFRB FPR1 CD79B CCR5	5.35e-05	355	31	7	MODULE_27
Computational	Genes in the cancer module 134.	CCR2 FPR1 CCR5	8.37e-05	30	31	3	MODULE_134
Computational	Genes in the cancer module 288.	CCR2 FPR1 CCR5	1.58e-04	37	31	3	MODULE_288
Computational	Genes in the cancer module 208.	IFITM3 FPR1 IFITM2 UNC79	4.17e-04	124	31	4	MODULE_208
Computational	Immune response and Ag processing and presentation.	IFITM3 FPR1 CD79B UNC79	4.43e-04	126	31	4	MODULE_345
Computational	Genes in the cancer module 108.	CCR2 FPR1 CCR5	5.43e-04	56	31	3	MODULE_108
Computational	Genes in the cancer module 436.	IFITM3 FPR1 CD79B UNC79	6.25e-04	138	31	4	MODULE_436
Computational	Genes in the cancer module 171.	IFITM3 FPR1 IFITM2 UNC79	6.25e-04	138	31	4	MODULE_171
Computational	Genes in the cancer module 46.	CCR2 FCER1G IFITM3 CD79B CCR5 IFITM2	7.89e-04	394	31	6	MODULE_46
Computational	Immune response.	CCR2 FCER1G IFITM3 CD79B CCR5 IFITM2	8.32e-04	398	31	6	MODULE_75
Computational	Genes in the cancer module 173.	ADORA2B FPR1	9.42e-04	16	31	2	MODULE_173
Computational	Inflammatory response.	CCR2 FPR1 CCR5	1.59e-03	81	31	3	MODULE_76
Computational	GPCR signaling pathways (immune and neuro).	CCR2 FPR1 CCR5	2.15e-03	90	31	3	MODULE_375
Computational	Genes in the cancer module 146.	CCR2 FPR1 CCR5	3.07e-03	102	31	3	MODULE_146
Computational	Genes in the cancer module 367.	CCR2 CCR5	3.11e-03	29	31	2	MODULE_367
Computational	Membranal receptors.	GABRE CCR2 FCER1G FPR1 CD79B CCR5	3.17e-03	517	31	6	MODULE_64
Disease	endometrial carcinoma, endometriosis	TLR10 OR9Q1 PGR	9.46e-07	11	54	3	EFO_0001065, EFO_1001512
Disease	progressive familial intrahepatic cholestasis (implicated_via_orthology)	ATP10B ATP10D	9.85e-06	3	54	2	DOID:0070221 (implicated_via_orthology)
Disease	posterior uveitis (is_implicated_in)	CCR2 CCR5	9.85e-06	3	54	2	DOID:12574 (is_implicated_in)
Disease	metabolic acidosis (biomarker_via_orthology)	RHCG SLC38A3	3.28e-05	5	54	2	DOID:0050758 (biomarker_via_orthology)
Disease	urticaria (is_implicated_in)	CCR2 CCR5	9.14e-05	8	54	2	DOID:1555 (is_implicated_in)
Disease	Coronavirus infectious disease (implicated_via_orthology)	CCR2 CCR5	1.17e-04	9	54	2	DOID:0080599 (implicated_via_orthology)
Disease	Kawasaki disease (is_implicated_in)	CCR2 CCR5	2.14e-04	12	54	2	DOID:13378 (is_implicated_in)
Disease	N-acetyltaurine measurement	C1QL3 SLC38A3	2.53e-04	13	54	2	EFO_0020023
Disease	Kuhnt-Junius degeneration (is_marker_for)	CCR2 PDGFRB	2.95e-04	14	54	2	DOID:10873 (is_marker_for)
Disease	–	CCR2 CCR5	3.88e-04	16	54	2	609423
Disease	Susceptibility to HIV infection	CCR2 CCR5	3.88e-04	16	54	2	cv:C1836230
Disease	sarcoidosis (is_implicated_in)	CCR2 CCR5	3.88e-04	16	54	2	DOID:11335 (is_implicated_in)
Disease	interstitial lung disease (is_marker_for)	CCR2 CCR5	9.60e-04	25	54	2	DOID:3082 (is_marker_for)
Disease	C-C motif chemokine 14 measurement	SLAMF8 OR10J4	1.12e-03	27	54	2	EFO_0008042
Disease	bowel opening frequency	MUC12 STX16	1.38e-03	30	54	2	EFO_0600084
Disease	granulocyte percentage of myeloid white cells	CCR2 PDGFRB CCR5 IFITM2	1.47e-03	268	54	4	EFO_0007997
Disease	CCL2 measurement	CCR2 PDGFRB OR10J4	1.61e-03	126	54	3	EFO_0004749

Protein segments in the cluster

Peptide	Gene	Start	Entry
NKILVPLVLLRQMLL	BCL2L13	151	Q9BXK5
VVILPVIMIILMIPI	BTN2A3P	246	Q96KV6
VLPPLLIMLVIYIKI	ADORA2B	191	P29275
MVLLLVILIPVLVSS	C1QL3	1	Q5VWW1
MVLLLLVAIPLLVHS	C1QL4	1	Q86Z23
MLLVLVVLIPVLVSS	C1QL1	1	O75973
LKIVILGLVLPLLVM	CCR5	196	P51681
MNIILEILLLLITII	HSD17B13	1	Q7Z5P4
IIMIQTLLIILFIIV	CD79B	161	P40259
MIILLQVLIPISLYV	ATP10B	371	O94823
MIILLQVLIPISLYV	ATP10D	376	Q9P241
LITVLGNLEMIILIL	OR9Q1	36	Q8NGQ5
ILGIFMTILLIIIPV	IFITM2	111	Q01629
MTILLIIIPVLVVQA	IFITM2	116	Q01629
LILGILMTILLIVIP	IFITM3	111	Q01628
LMTILLIVIPVLIFQ	IFITM3	116	Q01628
LVMLLLLALLILGIV	LMBR1	151	Q8WVP7
VVMVLVPLLLLLCVL	MMP15	626	P51511
LVVIMICVALVVLPL	KCNT1	311	Q5JUK3
MVLGILLLILAPLLL	DSG4	636	Q86SJ6
MWSPIIITILLILIQ	FFAR4	276	Q5NUL3
LMITRAIVLILPLLL	OR51F1	156	A6NGY5
MIPAVVLLLLLLVEQ	FCER1G	1	P30273
MDILVPLLQLLVLLL	METTL7B	1	Q6UX53
VVVLMAVLLLLALLT	MRC2	1416	Q9UBG0
MLSKVLPVLLGILLI	GABRE	1	P78334
IQLIPPLINLLMSIE	PGR	681	P06401
LLALVMILLPLLAVV	OR6P1	201	Q8NGX9
VLALLLSILILAMIP	MT-CYB	291	P00156
LILGILMTILLIIIP	nan	111	C9JQL5
LMTILLIIIPVLIFQ	nan	116	C9JQL5
IQLMPIIVLILVSLL	DNAJB14	251	Q8TBM8
IIVLILVSLLSQLMV	DNAJB14	256	Q8TBM8
VFVQLMPILILILVS	DNAJB12	246	Q9NXW2
MPILILILVSALSQL	DNAJB12	251	Q9NXW2
RNILGLVLPLLIMVI	CCR2	206	P41597
LPIIVVILMIPIAVC	BTN2A1	251	Q7KYR7
MLGQVVTLILLLLLK	CD244	1	Q9BZW8
LVVLTIISLIILIML	PDGFRB	541	P09619
ILPLLNLVGVVKLIM	OR1E3	321	Q8WZA6
VLLCVMNLIILVNLI	PANX2	296	Q96RD6
LLISLCVLVLPMVLI	OR10J4	201	P0C629
VALAVILPVLVLLIM	ERMAP	156	Q96PL5
LGVVLTLLVLMLIMV	TREML2	271	Q5T2D2
VSVTIILPLALMRQL	SLC38A3	196	Q99624
TALLIVTIVVIMLVL	TLR10	576	Q9BXR5
NLLIIIVSVLIILPL	SLC38A5	171	Q8WUX1
VMALLLTLPVIIRVT	FPR1	151	P21462
KLPLQTIMRLLQVLV	HID1	691	Q8IV36
LLSLLVMVISPVIQL	NSDHL	306	Q15738
LLLVTVVVPKMLVVI	OR6T1	71	Q8NGN1
RNILMLILPLILLNK	SLC10A5	141	Q5PT55
TIIVVKLITPLLLII	PIGW	241	Q7Z7B1
MQPRVLLVVALLALL	APOC3	1	P02656
LIVLTMPVPEILQLQ	RNLS	156	Q5VYX0
QMFQPIILLILILVL	SOGA3	911	Q5TF21
KMLVILILFVIIIVL	STX16	301	O14662
LVVVPVSLLLMLVTL	SLAMF8	236	Q9P0V8
LPLTCLLLQVIMVIL	RHCG	11	Q9UBD6
FILMVLIPLILLVLL	TMEM154	76	Q6P9G4
LIVVIIRMLVLLLDL	ZDHHC11B	231	P0C7U3
RIIIPVLLMLVFLAL	VRK2	491	Q86Y07
VLSELDIMVPLQLLI	UNC79	691	Q9P2D8
VMAVLLLALIILIIL	MUC12	5386	Q9UKN1
LLSILLILVVIAALM	LRP4	1731	O75096